ampelopsin has been researched along with methylnitrosourea in 1 studies
Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (methylnitrosourea) | Trials (methylnitrosourea) | Recent Studies (post-2010) (methylnitrosourea) |
---|---|---|---|---|---|
377 | 2 | 343 | 3,242 | 10 | 346 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, Q; Chang, H; Mi, M; Peng, X; Yu, X; Zhang, Q; Zhou, Y; Zhu, J | 1 |
1 other study(ies) available for ampelopsin and methylnitrosourea
Article | Year |
---|---|
Ampelopsin suppresses breast carcinogenesis by inhibiting the mTOR signalling pathway.
Topics: Alkylating Agents; Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Female; Flavonoids; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunoprecipitation; Methylnitrosourea; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2014 |